Cancer diagnostics News and Research

RSS

Quest Diagnostics' OVA1 ovarian cancer test cleared by the FDA

The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy.

From Quest Diagnostics 14 Sep 2009

Fau and MELK genes may help improve breast cancer diagnosis and treatment

Researchers at Keele University have identified two genes which may help improve the diagnosis and treatment of breast cancer patients.

11 Sep 2009

Lack of awareness in aged men reagarding prostate cancer treatment options

Prostate cancer remains one of the most commonly diagnosed cancers in the United States. In fact, one in six men will develop prostate cancer. It is also the second-leading cause of cancer death in the United States. But a recent survey suggests that many men at risk for the cancer still aren't aware of all available treatment options.

10 Sep 2009

Second-quarter fiscal 2009 results announced by Rosetta Genomics

Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, today reported financial results for the three and six months ended June 30, 2009.

9 Sep 2009

Aptamer nanoflares for molecular detection in living cells

By combining a gold nanoparticle with a unique family of nucleic acids, researchers at Northwestern University have created a new type of intracellular reporting system that with a flash of light reveals the presence and quantity of a wide variety of biologically important molecules. These so-called nanoflares could provide cancer biologists with a highly sensitive method of tracking complex biochemical processes in real time without interfering with those processes.

7 Sep 2009

Proton Therapy facility in Prague to implement Elekta's information management systems

Elekta (STO:EKTAB) will provide treatment planning and information management systems for a major Proton Therapy facility in Prague, Czech Republic. The software solutions will facilitate the highest quality of patient care and lead to improved clinical efficiency.

From Elekta 5 Sep 2009

Oncotype DX multigene expression test for breast cancer patients

In an effort to provide breast cancer patients with prompt, critical information about treatment options for use at their first visit with the medical oncologist, a number of leading U.S. surgeons request Genomic Health's Oncotype DX molecular test at the time of surgery or biopsy.

4 Sep 2009

Telephone counseling and referral service launched for ovarian cancer affected women

Women with ovarian cancer can now find immediate assistance to better cope with their diagnosis by calling 877-OV-HOPE-1 (877-684-6731), a new, free telephone counseling and referral service launched today by a unique partnership: L'Oreal Paris and its charitable partner, the Ovarian Cancer Research Fund (OCRF), and CancerCare, a national non-profit which provides free counseling and education services to individuals and families affected by cancer.

1 Sep 2009

MabCure featured in the August edition of Biotechnology Focus magazine

MabCure, Inc. (“MabCure”), a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, has been featured in the August edition of Biotechnology Focus, Canada's oldest and most successful magazine serving the Canadian life science industry.

31 Aug 2009

NanoBusiness 2009 conference to address nanotechnology advancements in various markets

The NanoBusiness Alliance, the world's leading nanotechnology trade association, today announced details of its expanded conference program for the 8th annual NanoBusiness 2009 conference and exhibition, which will held at McCormick Place in Chicago, IL, from September 8 – 10.

25 Aug 2009

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

A landmark report released today by the Lance Armstrong Foundation (LAF) estimates the total economic burden of new cancer cases at $305 billion in 2009. The findings are included in the report, "Breakaway: The Global Burden of Cancer - Challenges and Opportunities," released today in Dublin at the premiere LIVESTRONG Global Cancer Summit.

25 Aug 2009

University Of Phoenix and Odessa Chambliss Quality Of Life Fund collaborate to offer nursing scholarships

University of Phoenix today announced a partnership with Odessa Chambliss Quality of Life Fund to provide access to nursing education and help ensure the future of quality healthcare. Through this partnership, two full-tuition scholarships will be offered to nurses pursuing advanced degrees in the state of Florida.

21 Aug 2009

Hospitals treating more black cancer patients experience worse survival rates

Hospitals that treat more black cancer patients have worse survival rates on average for patients with breast and colon cancer, regardless of race, according to a new study from the University of Michigan Comprehensive Cancer Center.

21 Aug 2009

AMDL reports revenues of $3.2 million for second quarter of 2009

AMDL Inc., a US-based pharmaceutical company with major operations in China, today reported unaudited results and the filing of its Form 10-Q with the Securities and Exchange Commission ("SEC") for fiscal second quarter 2009.

19 Aug 2009

Brits risk late cancer diagnosis because of poor symptom awareness

One in seven people cannot name a single symptom of cancer, according to a Cancer Research UK survey published Monday.

19 Aug 2009

Aspirin improves survival after colorectal cancer diagnosis

Men and women who were diagnosed with colorectal cancer and began regular use of aspirin had a lower risk of overall and colorectal cancer death compared to patients not using aspirin, according to a study in the August 12 issue of JAMA.

18 Aug 2009

MRI increases chances of more extensive surgery over conservative approaches in breast cancer diagnosis

A new review says using magnetic resonance imaging (MRI) before surgery to assess the extent of early breast cancer has not been shown to improve surgical planning, reduce follow-up surgery, or reduce the risk of local recurrences.

13 Aug 2009

Aspirin improves survival after colorectal cancer diagnosis

11 Aug 2009

Regular use of aspirin after colorectal cancer diagnosis may reduce the risk of cancer death

In the August 12 issue of the Journal of the American Medical Association, the study's authors also find that the aspirin-associated survival advantage was seen primarily in patients with tumors expressing the COX-2 enzyme, a characteristic of two-thirds of colorectal cancers.

11 Aug 2009

Upstream Biosciences actively seeking licensors or acquirers for anti-parasitic drug discovery portfolio and cancer diagnostic platform

Upstream Biosciences Inc. (OTCBB: UPBS) has announced that the company is actively seeking licensors or acquirers for its novel anti-parasitic drug discovery portfolio and cancer diagnostic platform.

11 Aug 2009

Cancer diagnostics News and Research

Quest Diagnostics' OVA1 ovarian cancer test cleared by the FDA

Fau and MELK genes may help improve breast cancer diagnosis and treatment

Lack of awareness in aged men reagarding prostate cancer treatment options

Second-quarter fiscal 2009 results announced by Rosetta Genomics

Aptamer nanoflares for molecular detection in living cells

Proton Therapy facility in Prague to implement Elekta's information management systems

Oncotype DX multigene expression test for breast cancer patients

Telephone counseling and referral service launched for ovarian cancer affected women

MabCure featured in the August edition of Biotechnology Focus magazine

NanoBusiness 2009 conference to address nanotechnology advancements in various markets

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

University Of Phoenix and Odessa Chambliss Quality Of Life Fund collaborate to offer nursing scholarships

Hospitals treating more black cancer patients experience worse survival rates

AMDL reports revenues of $3.2 million for second quarter of 2009

Brits risk late cancer diagnosis because of poor symptom awareness

Aspirin improves survival after colorectal cancer diagnosis

MRI increases chances of more extensive surgery over conservative approaches in breast cancer diagnosis

Aspirin improves survival after colorectal cancer diagnosis

Regular use of aspirin after colorectal cancer diagnosis may reduce the risk of cancer death

Upstream Biosciences actively seeking licensors or acquirers for anti-parasitic drug discovery portfolio and cancer diagnostic platform

Cancer Research eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News